VacV Biotech
Description: VacV Biotech develops advanced viral-based cancer immunotherapies with enhanced tumor specificity, safety, and efficacy.
Country: UK
Based in: London
Founded: 2022
Funding Stage: Pre-Seed
Tags: ['Medical & Health', 'immunotherapy', 'software']
ACCESS DIRECTORY
Details about how we process your information are available in our Privacy Policy.
